Jun 04, 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
May 27, 2020
AbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfolio
Apr 29, 2020
UCB's Cimzia is Making Inroads in the Treatment of Axial Disease, with Significant Uptake in Non-Radiographic Axial Spondyloarthritis and a Positive Treatment Halo in Ankylosing Spondylitis
Apr 10, 2020
Visiongain Report Provides Critical Market-led Data on the $6.6bn Biosimilar Monoclonal Antibodies Market
Apr 01, 2020
Global Biosimilars Market (2020 to 2025) - New Indications and the Patent Expiry of Biologic Products Present Lucrative Opportunities
Mar 27, 2020
Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
Mar 18, 2020
Visiongain Report: Global Rheumatoid Arthritis Drugs Market Estimated to Grow at a CAGR of 0.6% in the Second Half of the Forecast Period
Feb 10, 2020
US Biosimilars Market , Dosage, Price & Clinical Pipeline Outlook 2025
Jan 12, 2020
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan
Dec 18, 2019
AbbVie Receives European Commission Approval of RINVOQ(TM) (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
Dec 17, 2019
The Biosimilars Market in the US: 2019 Payer Insights Report Featuring 47 Insights Supported by 199 Directly Quoted Comments from Industry Experts
Dec 16, 2019
Promising Early Launch Metrics for AbbVie's Rinvoq (upadacitinib) to Help JAK Inhibitors Solidify Their Position as Second-Line Leaders in Rheumatoid Arthritis, According to Spherix Global Insights
Sep 13, 2019
Novartis' Cosentyx and Pfizer's Xeljanz Leave the Most on the Table with Psoriatic Arthritis Switch Brands, According to Spherix Global Insights
Sep 03, 2019
North America accounted for the largest share, accounting for approximately 30% of the global market, in 2017
Aug 16, 2019
AbbVie Receives FDA Approval of RINVOQ(TM) (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheumatoid Arthritis
Aug 09, 2019
Amgen Wins Patent Case On Enbrel® (etanercept)
Jul 30, 2019
Favorable Government Regulations Drove the US Biologics Market to be the Largest at $67 Billion in 2018: The Business Research Company
Jul 29, 2019
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
Jul 16, 2019
Uptake of Biosimilars in the EU5 Blunts Share of AbbVie's Humira and Merck's Remicade in the Crohn's Disease and Ulcerative Colitis Markets, While a Black Cloud of Safety Concerns Still Follows Pfizer's Xeljanz
Jun 11, 2019
Visiongain Report Claims There is Huge Potential Within the $57bn Biosimilar Drugs Market